Phase I Dose-Escalation Study of Docetaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients With Advanced Esophageal Carcinoma

A dose-escalation study of docetaxel (DOC), cisplatin (CDDP), and 5-fluorouracil (5-FU; DCF combination regimen) was performed to determine the maximum-tolerated dose (MTD), recommended dose (RD) and dose-limiting toxicities (DLT) in advanced esophageal carcinoma. Eighteen patients with esophageal c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int Surg
Auteurs principaux: Satomura, Hitoshi, Nakajima, Masanobu, Sasaki, Kinro, Yamaguchi, Satoru, Domeki, Yasushi, Takahashi, Masakazu, Muroi, Hiroto, Kubo, Tsukasa, Kikuchi, Maiko, Otomo, Haruka, Ihara, Keisuke, Kato, Hiroyuki
Format: Artigo
Langue:Inglês
Publié: The International College of Surgeons, World Federation of General Surgeons and Surgical Specialists, Inc. 2015
Sujets:
Upper Gastrointestinal
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587522/
https://ncbi.nlm.nih.gov/pubmed/26414837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9738/INTSURG-D-14-00233.1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires